Correlation Between T2 Biosystms and BioAffinity Technologies,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both T2 Biosystms and BioAffinity Technologies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining T2 Biosystms and BioAffinity Technologies, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between T2 Biosystms and bioAffinity Technologies,, you can compare the effects of market volatilities on T2 Biosystms and BioAffinity Technologies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in T2 Biosystms with a short position of BioAffinity Technologies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of T2 Biosystms and BioAffinity Technologies,.

Diversification Opportunities for T2 Biosystms and BioAffinity Technologies,

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between TTOO and BioAffinity is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding T2 Biosystms and bioAffinity Technologies, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on bioAffinity Technologies, and T2 Biosystms is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on T2 Biosystms are associated (or correlated) with BioAffinity Technologies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of bioAffinity Technologies, has no effect on the direction of T2 Biosystms i.e., T2 Biosystms and BioAffinity Technologies, go up and down completely randomly.

Pair Corralation between T2 Biosystms and BioAffinity Technologies,

Given the investment horizon of 90 days T2 Biosystms is expected to under-perform the BioAffinity Technologies,. But the stock apears to be less risky and, when comparing its historical volatility, T2 Biosystms is 1.01 times less risky than BioAffinity Technologies,. The stock trades about -0.53 of its potential returns per unit of risk. The bioAffinity Technologies, is currently generating about -0.16 of returns per unit of risk over similar time horizon. If you would invest  94.00  in bioAffinity Technologies, on November 3, 2024 and sell it today you would lose (18.00) from holding bioAffinity Technologies, or give up 19.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

T2 Biosystms  vs.  bioAffinity Technologies,

 Performance 
       Timeline  
T2 Biosystms 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days T2 Biosystms has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
bioAffinity Technologies, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days bioAffinity Technologies, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

T2 Biosystms and BioAffinity Technologies, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with T2 Biosystms and BioAffinity Technologies,

The main advantage of trading using opposite T2 Biosystms and BioAffinity Technologies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if T2 Biosystms position performs unexpectedly, BioAffinity Technologies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies, will offset losses from the drop in BioAffinity Technologies,'s long position.
The idea behind T2 Biosystms and bioAffinity Technologies, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon